IBEX Ltd grants 4,000 RSUs to Chief People Officer

Inson Paul Joseph reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Inson Paul Joseph reported acquisition or exercise transactions in this Form 4 filing.

IBEX Ltd reported that Chief People Officer Paul Joseph Inson received a grant of 4,000 restricted stock units, each representing a right to one common share. The RSUs vest 25% on July 1, 2026, then 25% annually over the next three years, subject to continued service. After this award, he holds 31,469 common shares directly. On each vesting date, a portion of shares will be automatically withheld to cover tax obligations.

Insider Trade Summary

Grant/Award: 4,000 shares

Grant/Award 1 txn

Insider Inson Paul Joseph

Role Chief People Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	4,000	$0.00	$0.00

Holdings After Transaction: Common Shares — 31,469 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on July 1, 2026, with 25% of the RSUs vesting annually thereafter for the following three years, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IBEX (IBEX) report for Paul Joseph Inson?

IBEX reported that Chief People Officer Paul Joseph Inson received 4,000 restricted stock units. Each RSU represents a contingent right to one common share, awarded at no cash cost, increasing his directly held common shares to 31,469 after the grant.

How many IBEX (IBEX) shares were involved in this Form 4 filing?

The filing shows a grant of 4,000 restricted stock units tied to IBEX common shares. These RSUs convert one-for-one into common shares as they vest, subject to tax withholding in shares on each vesting date specified in the grant terms.

What is the vesting schedule for the 4,000 IBEX (IBEX) RSUs?

The 4,000 RSUs vest 25% on July 1, 2026, with another 25% vesting each year for the following three years. Vesting occurs only if Paul Joseph Inson remains in continuous service with the company on each applicable vesting date.

Did Paul Joseph Inson pay a purchase price for the IBEX (IBEX) RSUs?

No cash purchase price is shown for the 4,000 RSUs, which are reported at a price per share of 0.0000. This indicates the award was granted as equity compensation rather than bought in an open-market or negotiated cash transaction.

How many IBEX (IBEX) shares does Paul Joseph Inson own after this transaction?

After the RSU grant, Paul Joseph Inson is reported as beneficially owning 31,469 IBEX common shares directly. This figure reflects his holdings following the award but before any future vesting, share delivery, or tax-related share withholdings.

How will taxes be handled on the IBEX (IBEX) RSU vesting for Inson?

On each vesting date, shares of IBEX common stock will automatically be withheld to satisfy Paul Joseph Inson’s tax withholding obligations. This is described as a non-discretionary transaction, meaning the withholding occurs per the award’s preset terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 05:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Inson Paul Joseph

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	02/26/2026		A		4,000(1)	A	$0(1)	31,469	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on July 1, 2026, with 25% of the RSUs vesting annually thereafter for the following three years, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.